Xyosted 75 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FTFVR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,422
Award facts
- Contract value 100% obligated
- $1,422.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,422.13 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector supply. This non-set-aside, firm fixed-price delivery order was awarded on October 31, 2025, with an ultimate completion date of November 3, 2025. The product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health Agency and military healthcare systems. The company's extensive portfolio with DLA encompasses diverse pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. All reviewed contract awards with AmerisourceBergen have been competitively awarded without set-aside designations, demonstrating the company's capability to compete successfully for federal medical supply requirements. The DLA is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the key contractors supporting global military healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FTFVR?
SPE2DB26FTFVR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FTFVR worth?
The government has obligated $1,422 on SPE2DB26FTFVR.
Is contract SPE2DB26FTFVR an order under another contract?
Yes. SPE2DB26FTFVR is a delivery order under SPE2DB25D2204, an indefinite delivery contract.
Was contract SPE2DB26FTFVR competed?
The extent of competition for SPE2DB26FTFVR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award